DiaMedica Therapeutics Current Ratio 2015-2021 | DMAC

DiaMedica Therapeutics current ratio from 2015 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
DiaMedica Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.02B $0.00B 15.02
2021-03-31 $0.02B $0.00B 20.54
2020-12-31 $0.03B $0.00B 13.77
2020-09-30 $0.03B $0.00B 21.56
2020-06-30 $0.01B $0.00B 10.19
2020-03-31 $0.01B $0.00B 15.15
2019-12-31 $0.01B $0.00B 6.70
2019-09-30 $0.01B $0.00B 8.97
2019-06-30 $0.01B $0.00B 12.96
2019-03-31 $0.02B $0.00B 10.49
2018-12-31 $0.02B $0.00B 13.87
2018-09-30 $0.01B $0.00B 3.48
2018-06-30 $0.01B $0.00B 4.89
2018-03-31 $0.01B $0.00B 6.84
2017-12-31 $0.00B $0.00B 1.49
2017-09-30 $0.00B $0.00B 1.48
2017-06-30 $0.00B $0.00B 1.90
2017-03-31 $0.00B $0.00B 0.99
2016-12-31 $0.00B $0.00B 2.96
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
2016-03-31 $0.00B 0.00
2015-12-31 $0.00B $0.00B 0.19
2014-12-31 $0.00B $0.00B 0.14
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.076B $0.001B
DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76